Prosecution Insights
Prosecution Insights
28 pending office actions • 25 art units • 27 examiners • 0 of 28 (0%) have an AI response strategy ready • 59 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (7%) |
| §103 only | 17 (61%) |
| §102 only | 2 (7%) |
| §112 only | 3 (11%) |
| No statute on record | 4 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHATTERJEE, JAYANTA | 2 | 60.0% | +66.7% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +11.8% |
| BAIG, RUMAISA RASHID | 1 | 21.6% | +30.9% |
| YAMASAKI, ROBERT J | 1 | 67.5% | +42.9% |
| D ABREU, MICHAEL JOSEPH | 1 | 67.0% | +22.1% |
| NG, JONATHAN K | 1 | 34.9% | +13.5% |
| AL-AWADI, DANAH J | 1 | 53.6% | +14.0% |
| SABOKTAKIN, MARJAN | 1 | 58.0% | +14.9% |
| MAKHDOOM, SAMARINA | 1 | 71.4% | +30.1% |
| TATGE, LEXUS MARC | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18224413 | SYSTEMS FOR INFRASTRUCTURE DEGRADATION MODELLING AND METHODS OF USE THEREOF | OBAID, HAMZEH M | 104d overdue |
| 18571143 | RISK STRATIFICATION INTEGRATING MHEALTH AND AI | D ABREU, MICHAEL JOSEPH | 31d overdue |
| 18651381 | SYSTEMS AND METHODS FOR DIAGNOSIS AND/OR TREATING DEMYELINATING NEUROPATHY | BAIG, RUMAISA RASHID | 22d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18571127 | SYNTHETIC ECHO FROM ECG | NG, JONATHAN K | 119d overdue |
| 18680246 | PRODUCTION OF SINGLE DOMAIN COVID-19 ANTIBODIES IN PLANT CELLS | CHATTERJEE, JAYANTA | 60d overdue |
| 17813667 | COMPOSITIONS AND METHODS FOR AGROBACTERIUM MEDIATED TRANSFORMATION OF CHLOROPLASTS IN SEED PLANTS | CHATTERJEE, JAYANTA | 59d overdue |
| 18571143 | RISK STRATIFICATION INTEGRATING MHEALTH AND AI | D ABREU, MICHAEL JOSEPH | 31d overdue |
| 18651381 | SYSTEMS AND METHODS FOR DIAGNOSIS AND/OR TREATING DEMYELINATING NEUROPATHY | BAIG, RUMAISA RASHID | 22d overdue |
| 18758924 | Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy | COUGHLIN, MATTHEW P | 13d |
| 18597329 | Soluble Guanylyl Cyclase (GC1) Mimetic Polypeptides and Methods of Use Thereof | YAMASAKI, ROBERT J | 14d |
| 18528873 | NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF | AL-AWADI, DANAH J | 41d |
| Art Unit | Apps |
|---|---|
| 1662 | 2 |
| 3796 | 2 |
| 1658 | 2 |
| 1626 | 1 |
| 1657 | 1 |
| 3619 | 1 |
| 1615 | 1 |
| 3797 | 1 |
| 3648 | 1 |
| 1637 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18758924 | Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy | COUGHLIN, MATTHEW P | 1626 | §112 | Non-Final OA | 13d | Pending | Jun 28, 2024 |
| 18680246 | PRODUCTION OF SINGLE DOMAIN COVID-19 ANTIBODIES IN PLANT CELLS | CHATTERJEE, JAYANTA | 1662 | §103 | Non-Final OA | 60d overdue | Pending | May 31, 2024 |
| 18651381 | SYSTEMS AND METHODS FOR DIAGNOSIS AND/OR TREATING DEMYELINATING NEUROPATHY | BAIG, RUMAISA RASHID | 3796 | §103 | Non-Final OA | 22d overdue | Pending | Apr 30, 2024 |
| 18597329 | Soluble Guanylyl Cyclase (GC1) Mimetic Polypeptides and Methods of Use Thereof | YAMASAKI, ROBERT J | 1657 | §102 | Non-Final OA | 14d | Pending | Mar 06, 2024 |
| 18571143 | RISK STRATIFICATION INTEGRATING MHEALTH AND AI | D ABREU, MICHAEL JOSEPH | 3796 | §101 | Non-Final OA | 31d overdue | Pending | Dec 15, 2023 |
| 18571127 | SYNTHETIC ECHO FROM ECG | NG, JONATHAN K | 3619 | §103 | Non-Final OA | 119d overdue | Pending | Dec 15, 2023 |
| 18528873 | NANOPARTICLE (NP) COMPOSITIONS AND METHODS OF USE THEREOF | AL-AWADI, DANAH J | 1615 | Other | Non-Final OA | 41d | Pending | Dec 05, 2023 |
| 18384056 | SUPER-REGENERATIVE OSCILLATOR INTEGRATED METAMATERIAL LEAKY WAVE ANTENNA FOR MULTI-TARGET MOTION DETECTION AND RANGING | SABOKTAKIN, MARJAN | 3797 | §103 | Final Rejection | 77d | Pending | Oct 26, 2023 |
| 18381416 | MONITORING VITAL SIGNS OF MULTIPLE PERSONS VIA SINGLE PHASED-MIMO RADAR | MAKHDOOM, SAMARINA | 3648 | §103 | Non-Final OA | 82d | Pending | Oct 18, 2023 |
| 18484001 | MICRORNA COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF NERVOUS SYSTEM DYSFUNCTION | TATGE, LEXUS MARC | 1637 | Other | Non-Final OA | 7d | Pending | Oct 10, 2023 |
| 18278947 | UNSYMMETRICAL N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | HUI, SAN MING R | 1627 | §103 | Non-Final OA | 62d | Pending | Aug 25, 2023 |
| 18278932 | STERICALLY HINDERED N-ALIPHATIC N-HETEROCYCLIC CARBENE CATALYSTS AND METHODS USING SAME | QIAN, YUN | 1738 | §103 | Non-Final OA | 22d | Pending | Aug 25, 2023 |
| 18224413 | SYSTEMS FOR INFRASTRUCTURE DEGRADATION MODELLING AND METHODS OF USE THEREOF | OBAID, HAMZEH M | 3624 | §101 | Non-Final OA | 104d overdue | Pending | Jul 20, 2023 |
| 18209943 | SAFE AGILE HAZARD AVOIDANCE SYSTEM FOR AUTONOMOUS VEHICLES | HERRERA, MICHAEL J | 3668 | §103 | Non-Final OA | 79d overdue | Pending | Jun 14, 2023 |
| 18039917 | AMILORIDE DERIVATIVES AND METHODS OF USING SAME FOR THE TREATMENT OF VIRAL INFECTIONS | ROZOF, TIMOTHY R | 1625 | §102 | Non-Final OA | 60d overdue | Pending | Jun 01, 2023 |
| 18013368 | IDENTIFICATION OF ESTROGEN RECEPTOR POSITIVE (ER+) BREAST CANCERS THAT WILL NOT DEVELOP TAMOXIFEN RESISTANCE | SALMON, KATHERINE D | 1682 | §103 | Non-Final OA | 6d | Pending | Dec 28, 2022 |
| 18047822 | A MINIMAL CATALYTIC DI-NICKEL PEPTIDE CAPABLE OF SUSTAINED HYDROGEN EVOLUTION AND METHODS OF USE THEREOF | FRONDA, CHRISTIAN L | 1652 | §103 | Non-Final OA | 81d overdue | Pending | Oct 19, 2022 |
| 17906514 | CONTINUOUS MELT-COATING OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SURFACTANTS FOR DISSOLUTION ENHANCEMENT | ARNOLD, ERNST V | 1613 | Other | Non-Final OA | 23d overdue | Pending | Sep 16, 2022 |
| 17898995 | MASKED FLUOROGENIC COMPOUNDS AND METHODS OF USING THE SAME | ROGERS, JAMES WILLIAM | 1618 | §103 | Non-Final OA | 26d | Pending | Aug 30, 2022 |
| 17813667 | COMPOSITIONS AND METHODS FOR AGROBACTERIUM MEDIATED TRANSFORMATION OF CHLOROPLASTS IN SEED PLANTS | CHATTERJEE, JAYANTA | 1662 | §103 | Non-Final OA | 59d overdue | Pending | Jul 20, 2022 |
| 17791684 | COMPLEXES OF N-HETEROCYCLIC CARBENES FOR TRANSITION METAL CATALYSIS | CHEN, PO-CHIH | 1621 | §112 | Non-Final OA | 27d | Pending | Jul 08, 2022 |
| 17757609 | METHODS FOR INHIBITION OF ALPHA-SYNUCLEIN mRNA USING SMALL MOLECULES | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 29d | Pending | Jun 17, 2022 |
| 17765379 | TARGETED PULMONARY DELIVERY COMPOSITIONS AND METHODS USING SAME | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Other | Non-Final OA | 107d overdue | Pending | Mar 30, 2022 |
| 17753659 | Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses Thereof | RYAN, DOUGLAS CHARLES | 1635 | §103 | Final Rejection | 9d | Pending | Mar 10, 2022 |
| 17611241 | HIGH CONCENTRATION CELL PACKAGING AND SHIPPING | TRAN, KHOA NHAT | 1632 | §103 | Non-Final OA | 6d | Pending | Nov 15, 2021 |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | XIE, XIAOZHEN | 1674 | §103 | Non-Final OA | 12d | Pending | Aug 19, 2021 |
| 17343965 | ORGANIC COMPOUNDS | SZNAIDMAN, MARCOS L | 1628 | §112 | Non-Final OA | 1d overdue | Pending | Jun 10, 2021 |
| 17282883 | METHODS OF REDUCING TYPE 2 CYTOKINE-MEDIATED INFLAMMATION USING NEUROMEDIN PEPTIDES | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | 111d overdue | Pending | Apr 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial